Impact of vigabatrin on risk of relapse of infantile spasms
Abstract Objective Vigabatrin is an effective treatment for infantile epileptic spasms syndrome (IESS), but relapse remains a clinical challenge. The ideal dose and duration of treatment after response are unknown. We set out to identify treatment‐related predictors of IESS relapse after initial vigabatrin response. Methods We conducted a retrospective
Yaretson I. Carmenate +5 more
wiley +1 more source
Unraveling the complex role of intestinal microbiota in drug permeability: Insights from N-acetylcysteine. [PDF]
Tian C, He Z.
europepmc +1 more source
Bidirectional interactions between food‐derived sensory compounds, gut sensing and microbiota, host physiological feedback, and metabolite production within the food matrix collectively shape sensory perception, microbial dynamics, and metabolic health.
Mohammad Nazrul Islam Bhuiyan
wiley +1 more source
ESG performance, financing constraints, and workplace health investment: evidence from Chinese biopharmaceutical enterprises. [PDF]
Li A, Zhou S.
europepmc +1 more source
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. [PDF]
Mateescu DM +9 more
europepmc +1 more source
Stabilization strategies and advancements in lyophilization to preserve integrity and efficacy of next-generation biologicals. [PDF]
Maharjan R +9 more
europepmc +1 more source
Plasmid‐like DNA sequences frequently found in bovine milk and serum have been proposed as infectious agents promoting indirect carcinogenesis. This multi‐omics study detected immune cells positive for these bovine meat and milk factors (BMMFs) in patients with lung cancer, with BMMF expression inversely correlated with smoking intensity.
Nives Cecere +17 more
wiley +1 more source
Preclinical characterization of IBD0333, a novel CD24×4-1BB bispecific antibody with tumor-dependent agonistic activity for cancer immunotherapy. [PDF]
Jiang DC +6 more
europepmc +1 more source
Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
ABSTRACT With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential.
Shiyu Xia +11 more
wiley +1 more source
Pharmacological Activity of Kaurenoic Acid Nanocarriers and Formulation Considerations for Therapeutic Cancer Applications. [PDF]
Ikechukwu P, Agu R.
europepmc +1 more source

